As the world’s second largest pharmaceutical market, China has become one of the most vibrant markets for research and development investment on new drugs, biologics and medical devices. Chinese life science entrepreneurs have helped advance the mission to make available innovative therapies for patients of the world largest populated country – and beyond.
Professionals involved at all levels in the regulation, discovery, development, and life cycle management of health care products, will travel from China and around the world to witness transformational changes for China’s innovation and regulatory environment.
Let’s share the view points, knowledge, new technologic progress, and cross-cutting collaboration towards patient centric biopharma innovation in China.
Click Here to get more The 9th DIA China Annual Meeting Details.
EXHIBITION AND HOSTING
From the 9th DIA China Annual Meeting, the exhibition sales and services are taken over byChina Center for Food and Drug International Exchange (CCFDIE).